Savolitinib (volitinib, AZD6094, HMPL-504) is a novel, potent, and selective MET inhibitor currently in clinical development in various indications, including PRCC. The IC50 values of this compound for c-Met and p-Met are 5 nM and 3 nM, respectively. It shows exquisite selectivity for c-Met over 274 kinase.
Molecular Weight:
345.36
Purity:
99.84%
CAS Number:
[1313725-88-0]
Formula:
C17H15N9
Target:
c-Met
* VAT and and shipping costs not included. Errors and price changes excepted
